Allergy

Autoimmune Diseases

Biosimilars

COVID-19

Cannabidiol (CBD)

Cardiology

Compounding

Continuous Glucose Monitoring

Dermatology

Diabetes

Digestive Health

Endocrinology

Eye Health

Generics

Headache and Migraine

Immunization

Infectious Disease

Influenza

Medical Devices

Mental and Behavioral Health

Neurology

Obesity Management

Oncology

Nonopioid Pain Management

Pain Management

Pediatrics

Public Health

Rare Diseases

Respiratory

Rheumatology

Shingles

Substance Use Disorder

Technology and Data

Veterinary Pharmacy 

Women's Health

News

FDA Updates

Law and Advocacy

Technology Trends

Viewpoints

All News

Media

Around the Practice

In-Depth Insights

K-Casts

Script-Ed

Expert Interviews

Podcasts

Conferences

Conference Coverage

Conference Listing

Resources

Disease Awareness 

White Board Video

American Pharmacists Month

CME/CE

Partners

Publications

Drug Topics Journal

Total Pharmacy Journal

Events

Virtual Events

Total Pharmacy Solutions Summit

Business

Business Strategies

Patient Services

Pharmacy Inventory

Law and Regulations

All Business News

Practice Type

Independent Pharmacy

Chain Pharmacy

Specialty Pharmacy

Health System Pharmacy

Pharmacy Technicians

Subscribe

Articles

A study found that patients with obesity who were diagnosed with type 2 diabetes aged 50 or younger had the highest risk of dementia.

Type 2 Diabetes Diagnosis at Younger Age Linked with Increased Dementia Risk

On the most recent episode of Over the Counter, Steve Callahan, Senior Director of Advisory & Insights at MMIT, talked with us about biosimilars and the Inflation Reduction Act.

Impact of the Inflation Reduction Act on Biosimilar Pricing, Dispensing 

TaQuina Warren, PharmD, owner of Focus Pharmacy in Smyrna, Delaware, discussed her career journey and why pharmacists are so crucial to the interoperability of health care.

Q&A: An Independent Pharmacy Owner’s Perspective on Pharmacists in Health Care

A recent study showed that cognitive behavioral therapy could help reduce fatigue and improve concentration with moderate certainty.

CBT, Rehabilitation May Improve Symptoms of Long COVID

About

Advertise

Editorial

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Drug Topics

Facebook

LinkedIn

Spotlight

NCPA Annual Convention

1rem

Clinical

Child Abuse: Responsibilities and Protection of the Reporter

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

1.0 Credit / Law, Pain Management, Opioids


Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

Steve Callahan, Senior Director of Advisory & Insights at MMIT, discussed out-of-pocket costs and the impact biosimilars are predicted to have for patients in the future.

Q&A: The Future of Biosimilar Pricing at the Pharmacy Counter

Steve Callahan, Senior Director of Advisory & Insights at MMIT, sat down with Drug Topics to discuss industry trends behind biosimilars.

Q&A: A Closer Look at the Current State of Biosimilars in the Drug Market

Wolters Kluwer Health conducted a survey of just over 1000 respondents to get US adults’ feelings about notable trends in the pharmacy industry.

Over Half of US Population Concerned About Prescription Drug Access, Prices

Companies like ShiftRx are using technology to help solve the staffing shortage crisis in health care. 

How Technology Can Reduce Pharmacy Staff Burnout

A conversation with Sean Jeffery, PharmD, BCGP, FASCP, AGSF, at NCPA 2024.

Potential Applications, Risks of AI in the Pharmacy 

AI has significantly changed the health care landscape in recent years and has been applied to everything from data and information storage to diagnostic tools. The pharmacy profession has been no exception, with increasing interest in using AI for things like drug discovery, dosage form designing, polypharmacology, and hospital pharmacy.

 As AI continues to grow, there is no doubt that it will be playing a bigger role in the lives of independent pharmacists.

At the National Community Pharmacists Association (NCPA) 2024 Annual Convention and Expo, held October 26 to 29 in Columbus, Ohio, 

sat down with Sean Jeffery, PharmD, BCGP, FASCP, AGSF, director of pharmacy at Hartford HealthCare Integrated Care Partners and professor of pharmacy practice at the University of Connecticut, to discuss how AI may be used to improve pharmacy workflows, and potential risks associated with AI when it comes to patient data security and privacy.

“I think we’re actually still in the infancy of how AI is going to be applied within the pharmacy,” Jeffery said.

“There’s a real big opportunity here to leverage the connection with a patient,” he added. “This is a little bit more downstream, but think about the individuals that you are caring for in between their visits. Wouldn’t it be nice if you’re able to have a more durable, lasting, ongoing communication with them about their medication needs between those visits. That’s where I think AI has the ability to bridge that and create educational content, create ways of connecting to patients and keeping your pharmacy connected with them.”

Click here to follow along with our NCPA conference coverage.

Coverage of the National Community Pharmacists Association 2024 Annual Convention and Expo was supported by Red Sail, with independent editorial content creation on-site by the Drug Topics team.

1. Raza MA, Aziz S, Noreen M, et al. Artificial Intelligence (AI) in Pharmacy: An Overview of Innovations. 

. 2022 Dec 12;13(2):10.24926/iip.v13i2.4839. doi: 10.24926/iip.v13i2.4839. PMID: 36654703; PMCID: PMC9836757.

Videos

A conversation with Sean Jeffery, PharmD, BCGP, FASCP, AGSF, director of pharmacy at Hartford HealthCare Integrated Care Partners and professor of pharmacy practice at the University of Connecticut.

Potential Applications, Risks of AI in the Pharmacy | NCPA 2024

Melanue Marcus Surescripts 3

As pharmacists take on more clinical care, having access to clinical information on patients is crucial. In today’s current health care ecosystem, though, that’s tricky: “You’ve got different pharmacy technology involved in different pharmacies across the country…but it’s not scaled,” explained Melanie Marcus in an interview with 

Marcus is the Chief Marketing and Customer Experience Officer at 

 at the 2024 National Association of Chain Drug Stores Total Store Expo, held August 17 to August 19, 2024, in Boston, Massachusetts.

MedAdvisor, BEN Partner to Introduce AI-Driven Medication Advisor

“The electronic health record side of the world has been working on this issue of interoperability for years,” she said, “and Surescripts has been working with EHRs for years to do that.” In 2023, Surescripts exchanged almost 2 billion clinical records across EHRs across the country.

But, Marcus added, “We all know as patients, that’s not good enough.” That’s where federal stakeholders come in: Provisions of the 21st Century Cures Act and the Trust Exchange Framework and Common Agreement have led to the creation of Qualified Health Information Networks, or QHINs. “These QHINs will allow health information to be exchanged with their participants [and] once that happens, the QHINs will exchange 

 amongst themselves, so that all of the participants have access to the clinical information that they need about patients,” Marcus explained.

Ready to catch up on the rest of our conference coverage? 

 for more of our coverage of the 2024 National Association of Chain Drug Stores Total Store Expo.

Pharmacists must be able to view clinical information about patients in order to provide the best clinical care. 

Technology and Data

Latest News